A detailed history of 1620 Investment Advisors, Inc. transactions in Omnicell, Inc stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 2,212 shares of OMCL stock, worth $97,106. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,212
Previous 670 230.15%
Holding current value
$97,106
Previous $18,000 433.33%
% of portfolio
0.08%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$25.61 - $45.43 $39,490 - $70,053
1,542 Added 230.15%
2,212 $96,000
Q2 2024

Jul 23, 2024

BUY
$26.22 - $32.65 $17,567 - $21,875
670 New
670 $18,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.94B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track 1620 Investment Advisors, Inc. Portfolio

Follow 1620 Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1620 Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 1620 Investment Advisors, Inc. with notifications on news.